Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

MGRM | Monogram Orthopaedics, Inc.

Index- P/E- EPS (ttm)-0.56 Insider Own25.56% Shs Outstand29.25M Perf Week-3.23%
Market Cap91.32M Forward P/E- EPS next Y- Insider Trans0.00% Shs Float18.92M Perf Month-37.76%
Income-16.40M PEG- EPS next Q- Inst Own- Short Float / Ratio0.58% / 1.45 Perf Quarter-22.28%
Sales- P/S- EPS this Y-15.90% Inst Trans- Short Interest0.11M Perf Half Y-
Book/sh0.42 P/B7.14 EPS next Y- ROA-113.40% Target Price- Perf Year-
Cash/sh0.56 P/C5.34 EPS next 5Y- ROE-272.10% 52W Range2.90 - 48.99 Perf YTD-74.47%
Dividend- P/FCF- EPS past 5Y- ROI- 52W High-93.88% Beta-
Dividend %- Quick Ratio2.30 Sales past 5Y- Gross Margin- 52W Low3.45% ATR0.34
Employees27 Current Ratio2.30 Sales Q/Q- Oper. Margin- RSI (14)29.69 Volatility6.88% 8.90%
OptionableNo Debt/Eq0.00 EPS Q/Q21.40% Profit Margin- Rel Volume0.36 Prev Close3.07
ShortableYes LT Debt/Eq0.00 Earnings- Payout- Avg Volume75.71K Price3.00
Recom- SMA20-23.33% SMA50-32.26% SMA200-35.59% Volume26,946 Change-2.28%
Monogram Orthopaedics, Inc. focuses on developing a product solution architecture to enable mass personalized optimization of orthopedic implants. The company intends to produce and market robotic surgical equipment and related software, orthopedic implants, tissue ablation tools, navigation consumables, and other miscellaneous instrumentation for use in reconstructive joint replacement procedures. Its robot prototype executes optimized paths for high-precision insertion of optimized implants in synthetic bone specimens. The company was formerly known as Monogram Arthroplasty Inc. and changed its name to Monogram Orthopaedics, Inc. in March 2017. The company was incorporated in 2016 and is headquartered in Austin, Texas.